GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Notes Receivable

PharmaSGP Holding SE (XTER:PSG) Notes Receivable : €0.0 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE Notes Receivable?

PharmaSGP Holding SE's Notes Receivable for the quarter that ended in Mar. 2025 was €0.0 Mil.


PharmaSGP Holding SE Notes Receivable Historical Data

The historical data trend for PharmaSGP Holding SE's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE Notes Receivable Chart

PharmaSGP Holding SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

PharmaSGP Holding SE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaSGP Holding SE Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


PharmaSGP Holding SE Notes Receivable Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaSGP Holding SE Business Description

Traded in Other Exchanges
Address
Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166
PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.
Executives
Dr. Clemens Fischer Supervisory Board
Madlena Hohlefelder Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines